Health Care/Hospital

Leads Biolabs R&D Symposium: Platform Synergy and Multi-Mechanism Integration Reshape the Immuno-Oncology Landscape

NANJING, China, May 11, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs"; Stock Code: 9887.HK) successfully held its R&D Symposium in Shanghai. Under the theme "Leads Innovation, Future Forward", the event comprehensively presented the Company's strategic elevation from "mul...

2026-05-11 19:00 2484

Putting humanity back into the focus of 'technonatalism' in assisted reproduction

BEIJING, May 11, 2026 /PRNewswire/ -- Since the world's first IVF baby was born almost 50 years ago, assisted reproductive technologies have advanced spectacularly to help millions of infertile couples to achieve their dreams of parenthood. Yet, despite the power of so-called technonatalism hu...

2026-05-11 17:42 2416

Planning a Group Visit to Medtec Shanghai: A Corporate Buyer's Guide

SHANGHAI, May 11, 2026 /PRNewswire/ -- Sourcing complex medical device components is rarely a solo job. Building a secure supply chain requires direct input from product engineering, quality control, and executive procurement teams. Sending your entire group to theMedtec China exhibition

2026-05-11 14:45 1616

Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa

Avalere Health Japan is designed with the full healthcare experience in mind, launching with an elite integrated team that brings together market access, medical, and marketing specialists, along with strategic consulting expertise. TOKYO, May 11, 2026 /PRNewswire/ -- Avalere Health, a global str...

2026-05-11 13:30 1403

ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D

TOKYO, May 11, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical innovation, the upgrade simplifies compliance workflows to support efficient drug discov...

2026-05-11 08:00 1781

ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D

SEOUL, South Korea, May 11, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical innovation, the upgrade simplifies compliance workflows to support efficien...

2026-05-11 08:00 1697

RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear

World's Leading Provider of Cutting-Edge Smart Ring Solutions NEW YORK, May 10, 2026 /PRNewswire/ -- RingConn opened Gen 3 pre-orders on May 5th ahead of its official May 29th launch, marking the occasion with a feature on the iconic One Times Square billboard in New York City on the first day o...

2026-05-10 22:00 2150

Study pinpoints 45 years as the critical threshold for a significant downturn in male fertility

BEIJING, May 10, 2026 /PRNewswire/ -- Forty-five years has been identified as the critical age threshold at which elevated sperm DNA fragmentation significantly reduces fertility potential in men. High levels of DNA fragmentation, defined as a breakdown of genetic material inside sperm cells, ...

2026-05-10 17:00 2109

Emotional burden of infertility can undermine lifestyle choices that may help women conceive

BEIJING, May 10, 2026 /PRNewswire/ -- The emotional burden of infertility actively undermines the capacity of many women to make sustained lifestyle changes, including weight loss and physical activity, that can improve their chances of becoming pregnant. A global conference on assisted reprod...

2026-05-10 09:05 2561

ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D

NEWARK, Del., May 9, 2026 /PRNewswire/ -- ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrative process to a streamlined, purchase-based authorization model. This policy shift addresses the i...

2026-05-10 01:30 4046

South and East Asia identified as hotspots of global warming related impacts on male fertility

BEIJING, May 9, 2026 /PRNewswire/ -- A major new study has shown that South and East Asia dominate patterns of global warming related decline in male fertility with the strongest and most consistent evidence coming from India, Pakistan and the southern parts of China. The effects of increased ...

2026-05-09 15:01 3630

Psychosocial support is vital to help those living with infertility to overcome treatment barriers, including stigmas, myths and taboos about IVF

BEIJING, May 9, 2026 /PRNewswire/ -- Diverse cultural or religious values across the Asia Pacific region mean that many people living with infertility face challenging family or societal attitudes when considering assisted reproductive treatment to achieve their dreams of parenthood. In many c...

2026-05-09 09:00 4159

World's First | Mabwell's 9MW5211 Receives FDA Clearance for Clinical Trial Application

SHANGHAI, May 8, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Investigational New Drug (IND) application for 9MW5211, its independently developed novel antibody, has received clearance...

2026-05-09 08:00 3279

AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest

ROCKVILLE, Md., May 8, 2026 /PRNewswire/ -- USA -- AAVnerGene Inc. today announced the launch of AAVone®2.1, the next-generation evolution of its proprietary AAVone® single-plasmid AAV production system, designed to improve AAV vector productivity, full-capsid yield, manufacturing efficiency, and...

2026-05-08 20:26 4286

The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA

CHENGDU, China, May 8, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that the sNDA (the "Application") for the Company's TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) was accepted for review ...

2026-05-08 19:29 4113

What Sets Medtec China Apart from Other Medical Device Manufacturing Expos

SHANGHAI, May 8, 2026 /PRNewswire/ -- Building a successful medical device requires precise engineering, reliable materials, and a resilient supply chain. Finding the right partners to bring your vision to life is a major challenge. TheMedtec China trade show solves ...

2026-05-08 19:21 3983

TOOTOO Self-Develops Ultra-Olaflur, Achieving a New Breakthrough in Super Cavity Protection for Children's Toothpaste

* Acid erosion resistance increased by 5 times, remineralization effect 1.7 times higher than previous generation Olaflur HANGZHOU, China, May 8, 2026 /PRNewswire/ -- Recently, Chinese children's age-specific wash and care brand TOOTOO (a brand under Hangzhou Daoyu Xingqing Biotechnology Co., L...

2026-05-08 18:21 3278

BioQ Debuts at in‑cosmetics Global, Showcasing China's Advancing Strength in Ingredient Innovation

PARIS, May 8, 2026 /PRNewswire/ -- BioQ, the biotechnology affiliate of Chinese skincare brand GUYU, made its first appearance as a raw-material supplier at in-cosmetics Global, held April 14–16, 2026, in Paris. Widely regarded as the most prestigious stage for cosmetic ingredients, the event adm...

2026-05-08 17:34 2888

The 23rd World Congress on Breast Cancer and Breast Healthcare to Be Held in Tianjin

TIANJIN, China, May 8, 2026 /PRNewswire/ -- To further promote academic exchange and practical collaboration in the global field of breast health, and to advance the standardized prevention and treatment of breast cancer, the 23rd World Congress on Breast Cancer and Breast Healthcare will be held...

2026-05-08 17:06 2561

Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, May 8, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today annou...

2026-05-08 17:02 3079
12345 ... 859